Table 5 Urinalysis results by treatment modality
From: Characterizing substance users and risk profiles across treatment centers: insights from Iran
Test | MMT N:220 | DICs N:101 | TC N:48 | Article 16 N:101 | P-value | Total N: 470 |
|---|---|---|---|---|---|---|
Cocaine Negative (%) Positive (%) | 220(100) 0(0) | 101(100) 0(0) | 48(100) 0(0) | 101(100) 0(0) | – | 470(100) 0(0) |
Amphetamine Negative (%) Positive (%) | 175(79.55) 45(20.45) | 46(45.54) 55(54.46) | 38(79.17) 101(20.83) | 69(68.32) 32(31.68) | 0.000 | 328(69.79) 142(30.21) |
Methamphetamine Negative (%) Positive (%) | 179(81.36) 41(18.64) | 38(37.62) 63(62.38) | 34(70.83) 14(29.17) | 69(68.32) 32(31.68) | 0.000 | 320(68.09) 150(31.91) |
Cannabis Negative (%) Positive (%) | 194(88.18) 26(11.82) | 82(81.19) 19(18.81) | 43(89.58) 5(10.42) | 84(83.17) 17(16.83) | 0.27 | 403(85.74) 67(14.26) |
Methadone Negative (%) Positive (%) | 141(64.09) 79(35.91) | 17(16.38) 84(83.17) | 41(85.42) 7(14.58) | 86(85.15) 15(14.85) | 0.000 | 285(60.64) 185(39.36) |
Morphine Negative (%) Positive (%) | 43(19.55) 177(80.45) | 10(9.9) 91(90.1) | 29(60.42) 19(39.58) | 7(6.93) 94(93.07) | 0.000 | 89(18.94) 381(81.06) |
Tramadol Negative (%) Positive (%) | 216(98.18) 4(1.82) | 100(99.01) 1(0.99) | 47(97.92) 1(2.08) | 100(99.01) 1(0.99) | 0.89 | 463(98.51) 7(1.49) |
Benzodiazepines Negative (%) Positive (%) | 208(94.55) 12(5.45) | 85(84.16) 16(15.48) | 46(95.83) 2(4.17) | 101(100) 0(0) | 0.000 | 440(93.62) 30(6.38) |
Tricyclics Negative (%) Positive (%) | 213(96.82) 17(3.18) | 99(98.09) 2(1.98) | 48(100) 0(0) | 101(100) 0(0) | 0.18 | 461(98.09) 9(1.91) |
Buprenorphine Negative (%) Positive (%) | 196(89.09) 24(10.91) | 98(97.03) 3(2.97) | 47(97.92) 1(2.08) | 98(97.03) 3(2.97) | 0.006 | 439(93.4) 31(6.60) |